One half (1/2) Category 1A CME Credit available for this course.


  1. Summarize biology of PDL-1
  2. Review clinical utility of testing
  3. Compare testing with sample cases


  1. New methods of diagnosis or treatment
  2. Availability of new medication(s) or indication(s)


Kikm H, Chung JH, PD-LI testing in non-small cell lung cancer: past, present, future. Journakl of Pathology &Translational Medicine 2019;53(4):199-206

Core Competencies: 3,6